Dengue vaccine shows favorable safety profile in travelers from non-endemic regions
Dengue is a viral disease transmitted by Aedes mosquitoes. Dengue is characterized by high fever and can cause excruciating pain—hence its common name of break bone fever.
Due to the global spread of the mosquito vector, dengue is spreading in many regions. It is likely that cases will begin to be seen in the continental United States in the future.
The vaccine TAK-003 has a good tolerability profile in routine clinical practice among travelers from regions where dengue is not endemic.
The vaccine demonstrated effectiveness under real world conditions during a dengue outbreak in Brazil in 2024.
Due to the global spread of the mosquito vector, dengue is spreading in many regions. It is likely that cases will begin to be seen in the continental United States in the future.
The vaccine TAK-003 has a good tolerability profile in routine clinical practice among travelers from regions where dengue is not endemic.
The vaccine demonstrated effectiveness under real world conditions during a dengue outbreak in Brazil in 2024.
